3 results
Approved WMOCompleted
The primary objective of the study is to assess the safety and performance of Akesys Prava Sirolimus Eluting Bioresorbable Peripheral scaffold system (Akesys Prava
Approved WMOCompleted
To evaluate the feasibility of (1) the use of the Beter Voorbereid* application and the study procedures of a randomized controlled trial (finished in June 2019) and (2) evaluating the effectiveness of the *Beter Voorbereid* application on improved…
Approved WMOCompleted
To assess the safety and the efficacy on the activity part of the Steatosis Activity Fibrosis (SAF) histological score (inflammation and ballooning) of a 24-week treatment with two doses of lanifibranor (800, 1200 mg/24h) in NASH adult patients.